Some vaccines may reduce the risk of dementia through a double effect in which the jabs help protect the brain through their ...

As the newly appointed federal vaccine advisory panel prepares to reevaluate childhood vaccination schedules, Gov. Josh ...

Note that some links may require registration or subscription. Ahead of a 2-day meeting of the Advisory Committee on ...

Respiratory syncytial virus (RSV) causes severe illness in millions of young children each year.1 Globally, it is estimated that over 100 000 children younger than 5 years die each year from RSV; 97% ...

Despite efforts to expand healthcare coverage, a significant portion of the population still struggles to access quality, ...

The global GLP-1 agonists market, valued at USD 19.70 billion in 2024, is projected to grow at a CAGR of 10.20% to reach USD 52.03 billion by 2034. Driven by rising type 2 diabetes and obesity rates, ...

Logo On June 1, the cancer community gathered to mark the 38th National Cancer Survivors Day and bring attention to the c ...

By Maggie Fick and Jennifer Rigby LONDON (Reuters) -Drugmakers Bharat Biotech and GSK will cut the price of their malaria ...

Bharat Biotech and GSK plc will significantly reduce the price of their malaria vaccine, Mosquirix, to under $5 per dose by ...

The US Food and Drug Administration (FDA) has approved GSK's 200 mg/ml autoinjector of Benlysta for individuals aged five ...

Bharat Biotech and GSK will lower the malaria vaccine price to under $5 by 2028. This is due to better processes and more ...

Vaccine maker Bharat Biotech International Ltd and British biopharma giant GSK plc will be slashing the prices of the world’s ...